Hypertrophic cardiomyopathy and comorbidities. The importance of heart-team in off label recommendations.

Back

HFA Premium Access

Hypertrophic cardiomyopathy and comorbidities. The importance of heart-team in off label recommendations.

Session: Clinical Cases: Chronic Heart Failure and Comorbidities

Topic: Clinical

Speaker: Miss M. Calvo Lopez (Barcelona, ES)

Event: Heart Failure 2021

Congress Presentation

Add to my library

About the speaker

Miss Margarita Calvo Lopez

Hospital Clinic of Barcelona, Barcelona (Spain)

4 presentations

0 follower

8 more presentations in this session

A remarkable response to Sacubitril/Valsartan in severe cardiomyopathy secondary to cardiotoxic chemotherapy.

Speaker: Doctor R. Trueick (Dublin, IE)

Access

Slides

Video

Cardiac transplantation after oncologic diseases: a case of cardiotoxic cardiomyopathy.

Speaker: Doctor M. Tettamanti (Buenos Aires, AR)

Access

Slides

Video

Cardiac Non-Hodgkin Lymphoma: A long Journey to Diagnose.

Speaker: Doctor P. Trisnasari (Yogyakarta, ID)

Access

Slides

Video

Anticoagulation: a dilemma in Cardio-Oncology.

Speaker: Doctor P. Araujo Leite Medeiros (Braga, PT)

Access

Slides

Video

Isolated left ventricular apical hypoplasia.

Speaker: Doctor A. Dattani (Leicester, GB)

Access

Slides

Video

Access the full session

Clinical Cases: Chronic Heart Failure and Comorbidities

Speakers: Miss M. Calvo Lopez, Doctor R. Trueick, Doctor M. Tettamanti, Doctor P. Trisnasari, Doctor P. Araujo Leite Medeiros...

Access

About the event

Heart Failure 2021

29 June - 1 July 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources